BioCentury
ARTICLE | Clinical News

Elucigene FH20 regulatory update

August 1, 2011 7:00 AM UTC

The U.K.'s NICE issued draft guidance recommending against the use of the genetic tests Elucigene FH20 from Gen-Probe and LIPOchip from Progenika Biopharma S.A. (Derio, Spain) to confirm a clinical ...